Scientists at Clay Center, Neb., have collaborated to produce the first gene-edited calf with resistance to bovine viral diarrhea virus (BVDV), a virus that costs the U.S. cattle sector billions of dollars annually.
To identify unique proteins that can be used for interventions against BRD, scientists took a closer look at the genetic material of multiple strains of three groups of bacteria commonly implicated with the disease.
